The Use of Directed Probiotics in ME/CFS
Recruiting Phase 2 NCT06211062
Study Description
Evaluating the Effects of a Probiotic Supplement on Gastrointestinal Symptoms in Chronic Fatigue Syndrome
Study Details
- Registry ID:
- NCT06211062
- Conditions:
- ME/CFS, IBS - Irritable Bowel Syndrome
- Phase:
- Phase 2
- Target Enrollment:
- 100 participants
- Start Date:
- Age Range:
- 45–70 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Institute for Neuroimmune Medicine
Fort Lauderdale, Florida, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.